Mutations of the BRAF gene in human cancerHelen Davies, Richard Wooster, Vivian Kosmidou et al.|Nature|2002Cited by 10.7k
The emerging role of FTY720 (Fingolimod) in cancer treatmentChristopher B. White, Dmitri Pchejetski, Heba Alshaker et al.|Oncotarget|2016Cited by 174
Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancerQi Wang, Dmitri Pchejetski, Heba Alshaker et al.|Scientific Reports|2017Cited by 82
The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and UrineHayley C. Whitaker, David E. Neal, Zsofia Kote‐Jarai et al.|PLoS ONE|2010Cited by 81
Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1Heba Alshaker, Dmitri Pchejetski, Qi Wang et al.|Oncotarget|2016Cited by 36